Lord, Abbett & Co’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $27.3M | Sell |
|
|||||
|
2024
Q4 | $33.8M | Sell |
|
|||||
|
2024
Q3 | $51.7M | Sell |
|
|||||
|
2024
Q2 | $72M | Sell |
|
|||||
|
2024
Q1 | $87.6M | Sell |
|
|||||
|
2023
Q4 | $76.7M | Sell |
|
|||||
|
2023
Q3 | $77.9M | Sell |
|
|||||
|
2023
Q2 | $98.9M | Sell |
|
|||||
|
2023
Q1 | $77M | Sell |
|
|||||
|
2022
Q4 | $101M | Buy |
|
|||||
|
2022
Q3 | $84.5M | Buy |
|
|||||
|
2022
Q2 | $73.4M | Sell |
|
|||||
|
2022
Q1 | $78.4M | Buy |
|
|||||
|
2021
Q4 | $82.1M | Buy |
|
|||||
|
2021
Q3 | $55.7M | Sell |
|
|||||
|
2021
Q2 | $81M | Sell |
|
|||||
|
2021
Q1 | $107M | Buy |
|
|||||
|
2020
Q4 | $6.86M | Sell |
|
|||||
|
2020
Q3 | $5.05M | Sell |
|
|||||
|
2020
Q2 | $5.87M | Sell |
|
|||||
|
2020
Q1 | $9.37M | Buy |
|
|||||
|
2019
Q4 | $9.01M | Sell |
|
|||||
|
2019
Q3 | $7.56M | Buy |
|